This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmaceuticals: Other
Health Technology
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cipla stocks are traded under the ticker CPLFY.
When is the next Cipla earnings date?▼
Cipla is going to release the next earnings report on May 08, 2026.
What were Cipla earnings last quarter?▼
CPLFY earnings for the last quarter are 0.09 USD per share, whereas the estimation was 0.17 USD resulting in a -45.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Cipla pay dividends?▼
Yes, CPLFY dividends are paid annual. The last dividend per share was 0.18 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cipla have?▼
As of April 02, 2026, the company has 30,313 employees.
In which sector is Cipla located?▼
Cipla operates in the Health Care sector.
When did Cipla complete a stock split?▼
The last stock split for Cipla was on April 24, 2006 with a ratio of 5:2.